| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 812-818, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
MH Stoler, GE Nichols, M Symbula and LM Weiss
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Over the last decade, it has been noted that nodular lymphocytic and/or histiocytic predominance Hodgkin's disease (NLPHD) has clinical, histological, and immunophenotypical differences from classical Hodgkin's disease, but it is not clear whether NLPHD represents a B- cell neoplasm or merely an unusual B-lineage reactive condition. We evaluated 36 cases of LPHD (31 nodular, 5 diffuse) for evidence of B- cell clonality by immunohistochemistry for light-chain protein using polyclonal antibodies and microwave antigen retrieval, and by a highly sensitive in situ hybridization technique for light-chain mRNA using 3H- labeled antisense RNA probes. We found monotypic light-chain restriction for kappa protein in 36% of cases, with no clear predominance for either light-chain protein in the other cases. By in situ hybridization, 80% of the evaluable cases showed clear evidence of light-chain monotypsim, with 96% of cases monotypic for kappa mRNA and one case monotypic for lambda mRNA. In virtually all of these cases, the L&H cells were found to be monotypic, consistent with monoclonality. In about one-half of these cases, a small lymphocytic component was also found to be monotypic. Our data support the hypothesis that NLPHD and its rare diffuse variant represent a monotypic B-cell neoplasm, almost always of kappa light-chain type. NLPHD represents a neoplasm distinct from classical Hodgkin's disease.
This article has been cited by other articles:
![]() |
K J Flavell and P G Murray Hodgkin's disease and the Epstein-Barr virus Mol. Pathol., October 1, 2000; 53(5): 262 - 269. [Abstract] [Full Text] |
||||
![]() |
T. Marafioti, M. Hummel, H.-D. Foss, H. Laumen, P. Korbjuhn, I. Anagnostopoulos, H. Lammert, G. Demel, J. Theil, T. Wirth, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription Blood, February 15, 2000; 95(4): 1443 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Braeuninger, R. Kuppers, J. G. Strickler, H.-H. Wacker, K. Rajewsky, and M.-L. Hansmann Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells PNAS, August 19, 1997; 94(17): 9337 - 9342. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Marafioti, M. Hummel, I. Anagnostopoulos, H.-D. Foss, B. Falini, G. Delsol, P. G. Isaacson, S. Pileri, and H. Stein Origin of Nodular Lymphocyte-Predominant Hodgkin's Disease from a Clonal Expansion of Highly Mutated Germinal-Center B Cells N. Engl. J. Med., August 14, 1997; 337(7): 453 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohno, J. A. Stribley, G. Wu, S. H. Hinrichs, D. D. Weisenburger, and W. C. Chan Clonality in Nodular Lymphocyte-Predominant Hodgkin's Disease N. Engl. J. Med., August 14, 1997; 337(7): 459 - 466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |